Literature DB >> 7678375

Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy.

T Chaen1, N Watanabe, G Mogi, K Mori, M Takeyama.   

Abstract

To clarify the role of substance P (SP) and vasoactive intestinal peptide (VIP) in nasal allergy, we measured their concentrations in the nasal secretions and plasma of normal subjects and patients with nasal allergy to house dust and Japanese cedar pollen by competitive enzyme-linked immunoassay. The mean levels of SP (224 pmol/L) and VIP (41.6 pmol/L) in the nasal secretions of normal subjects were significantly higher than those in plasma (SP 3.04 pmol/L and VIP 1.04 pmol/L; p < .01). The mean levels of SP and VIP in the nasal secretions of the pollinosis group were significantly higher than those of the control group (p < .05 and p < .01), while the levels of the house dust allergy group were not higher than those of the control group. Intranasal allergen challenge significantly reduced SP levels in the nasal secretions of the allergy groups, while it did not influence VIP levels in the nasal secretions. These findings suggest that SP and VIP are actively secreted into the nose and may play an important role in the allergic reaction on the surface of the human nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678375     DOI: 10.1177/000348949310200104

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  5 in total

1.  Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.

Authors:  Gregory D Scott; Allison D Fryer
Journal:  Chem Immunol Allergy       Date:  2012-06-26

2.  Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells.

Authors:  S Fujieda; J A Waschek; K Zhang; A Saxon
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

3.  Allergic and idiopathic rhinitis: an ultrastructural study.

Authors:  Stephan Knipping; H J Holzhausen; A Riederer; T Schrom
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-06       Impact factor: 2.503

4.  [Ultrastructural changes in allergic rhinitis vs. idiopathic rhinitis].

Authors:  S Knipping; H J Holzhausen; A Riederer; T Schrom
Journal:  HNO       Date:  2008-08       Impact factor: 1.284

5.  Model for Studying Anti- Allergic Drugs for Allergic Conjunctivitis in Animals.

Authors:  Yosuke Nakazawa; Mikako Oka; Makoto Takehana
Journal:  Open Med (Wars)       Date:  2017-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.